GlassScriptPhysician profile
Bryan Jeanfreau
NPI 1538229935
$1,731.16
in general payments reported to CMS, 2019-2025
19 companies · $184 in 2025
The $184 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $117 · 2021: $459 · 2022: $318 · 2023: $419 · 2024: $85.49 · 2025: $184.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $688.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $688.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $275.28 | 2019-2024 | Tecnis Iol, Catalys System, Tecnis Simplicity |
| Sight Sciences, INC. | $209.53 | 2022-2025 | Tearcare System, Omni Surgical System |
| Aerie Pharmaceuticals, INC. | $188.97 | 2019-2021 | |
| Ivantis, INC | $187.74 | 2021 | |
| Glaukos Corporation | $168.32 | 2021-2023 | |
| Optos, INC. | $98.10 | 2020 | |
| Tarsus Pharmaceuticals, INC. | $91.64 | 2025 | Xdemvy |
| Alcon Vision LLC | $82.83 | 2019-2023 | Total30 |
| Allergan, INC. | $81.25 | 2019-2021 | |
| Abbvie INC. | $75.96 | 2022-2023 | |
| Mallinckrodt Hospital Products INC. | $66.13 | 2022-2023 | Acthar |
| Sun Pharmaceutical Industries INC. | $44.15 | 2019-2020 | |
| Oyster Point Pharma, INC. | $35.99 | 2023 | Tyrvaya |
| Biotissue Holdings INC. | $32.26 | 2023 | |
| Coopervision INC. | $23.99 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyepoint US, INC. | $19.48 | 2019 | |
| Dompe US, INC. | $18.85 | 2019 | |
| Horizon Therapeutics Plc | $15.69 | 2023 | Tepezza |
| Astellas Pharma US INC | $15.00 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Jeanfreau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.